Abstract 8 Health-Related Quality of Life (HRQL) Following Transplantation with Omidubicel Versus Umbilical Cord Blood (UCB) in Patients with Hematologic Malignancies: Results from a Phase III Randomized, Multicenter Study

INTRODUCTION: Omidubicel, an advanced cell therapy used for allogeneic hematopoietic stem cell transplant has demonstrated faster hematopoietic recovery, shorter hospitalization, and lower rates of bacterial, viral, and invasive fungal infections compared with umbilical cord blood (UCB) in a phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chenyu, Sajeev, Gautam, Sung, Anthony, Stiff, Patrick, Brunstein, Claudio, Cutler, Corey, Sanz, Guillermo, Lindemans, Caroline, Rezvani, Andrew, Hanna, Rabi, Koh, Liang, Maziarz, Richard, Hwang, William, Song, Yan, Liu, Qing, Manghani, Rocio, Sivaraman, Smitha, Signorovitch, James, Horwitz, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trials – Hematopoietic Stem Cell Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446902/
http://dx.doi.org/10.1093/stcltm/szac057.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446902/
http://dx.doi.org/10.1093/stcltm/szac057.008

Ejemplares similares